✦ LIBER ✦

Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8–10 cancers

✍ Scribed by Andriole, G.L.

Book ID: 123100082
Publisher: Elsevier Science
Year: 2008
Weight: 41 KB
Volume: 2008
Category: Article
ISSN: 0084-4071
DOI: 10.1016/S0084-4071(08)79170-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of prostate-specific antigen test

Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8–10 cancers

✍ Stephen A. Boorjian; R. Jeffrey Karnes; Laureano J. Rangel; Eric J. Bergstralh; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

397Clinical and pathological outcome aft

397Clinical and pathological outcome after radical prostatectomy for prostate cancer with a preoperative gleason score 8 to 10

✍ P. Bastian; M. Gonzalgo; S. Freedland; L. Mangold; A. Partin 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Clinical and pathologic outcome after ra

Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10

✍ Patrick J. Bastian; Mark L. Gonzalgo; William J. Aronson; Martha K. Terris; Chri 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

Prostatectomy: Undertreatment: Re: Clini

Prostatectomy: Undertreatment: Re: Clinical and Pathologic Outcome after Radical Prostatectomy for Prostate Cancer Patients with a Preoperative Gleason Sum 8 to 10

✍ Henk Van der Poel 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 38 KB

A Multivariate Analysis of Clinical and

A Multivariate Analysis of Clinical and Pathological Factors that Predict for Prostate Specific Antigen Failure after Radical Prostatectomy for Prostate Cancer

✍ D'Amico, Anthony V.; Whittington, Richard; Malkowicz, S. Bruce; Schultz, Delray; 📂 Article 📅 1995 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 904 KB

Radical prostatectomy for clinically adv

Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome

✍ John F. Ward; Jeffrey M. Slezak; Michael L. Blute; Erik J. Bergstralh; Horst Zin 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB